Ledger.Open graph →
SEC Form D · filed April 8, 2014

CHRONIX BIOMEDICAL INC

Offering
$14.5M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN JOSE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Behzad Aghazadeh · New York, NYExec · DirectorSandip K. Agarwala · Cambridge, MADirectorThomas H. Cardiff · Pittsburgh, PADirectorAlan Weber · Armonk, NYDirectorCorbin J. Robertson Iii · Houston, TXDirectorScott Epstein · New York, NYDirectorNeil S. Fineman · Las Vegas, NVDirectorEric J. Wichterman · Phoenix, AZExecMichael V. Oh, Md · Pittsburgh, PADirectorMark H. Fiskio · Newton, MADirectorCasey A. Fries · New York, NYDirectorVicky Schiff · CALABASAS, CAExec · DirectorEthan Penner · CALABASAS, CADirectorJereme Thaxton · Salt Lake City, UTExecDaniel Goodman · San Francisco, CADirectorAnurag Pal · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗